Source: MarketScreener

Zosano Pharma: SHAREHOLDER ALERT: Zosano Pharma Corp. Investigated for Possible Securities Laws Violations by Block & Leviton LLP; Investors Should Contact the Firm

(marketscreener.com) BOSTON, Oct. 22, 2020 -- On September 30, 2020, Zosano Pharma Corp. stunned the market when it announced that it had received "a discipline review letter from the U.S. Food and Drug Administration" in connection with Zosano's new drug application for Qtrypta . Per Zosano's announcement, the FDA...https://www.marketscreener.com/news/latest/SHAREHOLDER-ALERT-Zosano-Pharma-Corp-Investigated-for-Possible-Securities-Laws-Violations-by-Block--31593783/?utm_medium=RSS&utm_content=20201022

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Steven Lo's photo - President & CEO of Zosano Pharma

President & CEO

Steven Lo

CEO Approval Rating

83/100

Zosano Pharma is a clinical-stage biopharmaceutical company that researches, develops and commercializes novel therapeutics to treat migraines. Read more